An official website of the United States government
Use of COVID-19 Vaccines in the United States
Interim Clinical Considerations
Summary of recent changes (last updated September 6, 2024):
- Recommendations for the use of 2024–2025 Novavax COVID-19 Vaccine in people ages 12 years and older
- Updated guidance in the Interchangeability of COVID-19 vaccines section and in Appendix B on completion of an initial vaccination series if vaccine doses from different manufacturers are administered in certain circumstances
Reference Materials
- COVID-19 Vaccine Product Information (Updated 9/27/24)
- 2024–2025 COVID-19 Vaccine Immunization Schedule for People 6 Months of Age and Older (Updated 9/19/24)
Get Email Updates
Receive email updates about this page.
Special Situations and Populations
References and Previous Updates